Cargando…

Metabolic benefits of 1-(3-(4-(o-tolyl)piperazin-1-yl)propyl)pyrrolidin-2-one: a non-selective α-adrenoceptor antagonist

PURPOSE: Previous studies have shown that several components of the metabolic syndrome, such as hypertension, obesity or imbalanced lipid and carbohydrate homeostasis, are associated with the sympathetic nervous system overactivity. Therefore, the inhibition of the adrenergic nervous system seems to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kotańska, Magdalena, Kulig, Katarzyna, Marcinkowska, Monika, Bednarski, Marek, Malawska, Katarzyna, Zaręba, Paula
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902538/ https://www.ncbi.nlm.nih.gov/pubmed/29110282 http://dx.doi.org/10.1007/s40618-017-0779-7

Ejemplares similares

Metabolic and cardiovascular benefits and risks of 4-hydroxy guanabenz hydrochloride: α(2)-adrenoceptor and trace amine-associated receptor 1 ligand
por: Kotańska, Magdalena, et al.
Publicado: (2023)

N-p-Tolylpyrrolidine-1-carboxamide
por: Li, Yu-Feng
Publicado: (2012)

4-(o-Tolyl)piperazin-1-ium chloride
por: Fun, Hoong-Kun, et al.
Publicado: (2011)

1-[(Pyrrolidin-1-yl)(p-tolyl)methyl]naphthalen-2-ol
por: Wan, Chuanwei, et al.
Publicado: (2008)

Piperazine-Derived α(1D/1A) Antagonist 1- Benzyl-N- (3-(4- (2-Methoxyphenyl) Piperazine-1-yl) Propyl) -1H- Indole-2- Carboxamide Induces Apoptosis in Benign Prostatic Hyperplasia Independently of α1-Adrenoceptor Blocking
por: Xiao, Qing, et al.
Publicado: (2021)

Manifestations of Liver Impairment and the Effects of MH-76, a Non-Quinazoline α1-Adrenoceptor Antagonist, and Prazosin on Liver Tissue in Fructose-Induced Metabolic Syndrome
por: Kubacka, Monika, et al.
Publicado: (2023)

Structures 4-n-propyl Piperazines as Non-Imidazole Histamine H3 Antagonists
por: Olczak, Andrzej, et al.
Publicado: (2021)

MH-76, a Novel Non-Quinazoline α(1)-Adrenoceptor Antagonist, but Not Prazosin Reduces Inflammation and Improves Insulin Signaling in Adipose Tissue of Fructose-Fed Rats
por: Kubacka, Monika, et al.
Publicado: (2021)

2-Amino-6-(pyrrolidin-1-yl)-4-p-tolylpyridine-3,5-dicarbonitrile
por: Inglebert, S. Antony, et al.
Publicado: (2011)

QSAR studies on a number of pyrrolidin-2-one antiarrhythmic arylpiperazinyls
por: Nowaczyk, Alicja, et al.
Publicado: (2011)

Chemically Homogenous Compounds with Antagonistic Properties at All α(1)-Adrenoceptor Subtypes but not β(1)-Adrenoceptor Attenuate Adrenaline-Induced Arrhythmia in Rats
por: Pytka, Karolina, et al.
Publicado: (2016)

1,4-Bis{3-[4-(dimethylamino)benzylideneamino]propyl}piperazine
por: Xu, Rui-Bo, et al.
Publicado: (2009)

6-[3-(p-Tolylsulfonylamino)propyl]diquinothiazine
por: Jeleń, Małgorzata, et al.
Publicado: (2013)

Antiarrhythmic and antioxidant activity of novel pyrrolidin-2-one derivatives with adrenolytic properties
por: Sapa, Jacek, et al.
Publicado: (2010)

Evaluation of antinociceptive and antioxidant properties of 3-[4-(3-trifluoromethyl-phenyl)-piperazin-1-yl]-dihydrofuran-2-one in mice
por: Sałat, Kinga, et al.
Publicado: (2013)

2-Propyl 3,3-dibromo-2-hydroxypyrrolidine-1-carboxylate
por: Nichol, Gary S., et al.
Publicado: (2010)

Novel Functionalized Amino Acids as Inhibitors of GABA Transporters with Analgesic Activity
por: Gryzło, Beata, et al.
Publicado: (2021)

5-Propyl-6-(p-tolylsulfanyl)pyrimidine-2,4(1H,3H)-dione
por: Al-Omary, Fatmah A. M., et al.
Publicado: (2014)

3-Chloro-6-{4-[3-(4-chlorophenoxy)propyl]piperazin-1-yl}pyridazine
por: Wang, Hongliang, et al.
Publicado: (2010)

KD-64—A new selective A(2A) adenosine receptor antagonist has anti-inflammatory activity but contrary to the non-selective antagonist—Caffeine does not reduce diet-induced obesity in mice
por: Kotańska, Magdalena, et al.
Publicado: (2020)

4,4′-[Piperazine-1,4-diylbis(propylenenitrilomethylidyne)]diphenol
por: Xu, Ruibo, et al.
Publicado: (2009)

1-Diphenylmethyl-4-[3-(4-fluorobenzoyl)propyl]piperazine-1,4-diium dichloride monohydrate
por: Wang, Jing, et al.
Publicado: (2011)

Pelanserin: 3-[3-(4-phenylpiperazin-1-yl)propyl]quinazoline-2,4(1H,3H)-dione
por: Aguirre Hernández, Gerardo, et al.
Publicado: (2014)

2-[(3-Propylsulfanyl-5-p-tolyl-4H-1,2,4-triazol-4-yl)iminomethyl]phenol
por: Wang, Wei, et al.
Publicado: (2011)

Repurposing of α1-Adrenoceptor Antagonists: Impact in Renal Cancer
por: Mihalopoulos, Meredith, et al.
Publicado: (2020)

Preliminary Evidence of the Potent and Selective Adenosine A2B Receptor Antagonist PSB-603 in Reducing Obesity and Some of Its Associated Metabolic Disorders in Mice
por: Kotańska, Magdalena, et al.
Publicado: (2022)

3′-Hydroxymethyl-1′-methyl-3′-nitro-4′-(o-tolyl)spiro[indoline-3,2′-pyrrolidin]-2-one
por: Gangadharan, Rajeswari, et al.
Publicado: (2010)

[(Pyrrolidin-1-yl)carbothioylsulfanyl]methyl pyrrolidine-1-carbodithioate
por: Chou, Wei-Lung, et al.
Publicado: (2010)

The affinity and selectivity of α‐adrenoceptor antagonists, antidepressants, and antipsychotics for the human α1A, α1B, and α1D‐adrenoceptors
por: Proudman, Richard G. W., et al.
Publicado: (2020)

Piperazine-1,4-diium bis(hydrogen 2-propyl-1H-imidazole-4,5-dicarboxylate) monohydrate
por: Gao, Zhu-Qing, et al.
Publicado: (2010)

The Role of α1-Adrenoceptor Antagonists in the Treatment of Prostate and Other Cancers
por: Batty, Mallory, et al.
Publicado: (2016)

Evaluation of Some Safety Parameters of Dual Histamine H(3) and Sigma-2 Receptor Ligands with Anti-Obesity Potential
por: Mika, Kamil, et al.
Publicado: (2023)

2-p-Tolyl-1-p-tolylmethyl-1H-benzimidazole
por: Liu, Ting
Publicado: (2009)

β(1) Adrenoceptor antagonistic effects of the supposedly selective β(2) adrenoceptor antagonist ICI 118,551 on the positive inotropic effect of adrenaline in murine hearts
por: Pecha, Simon, et al.
Publicado: (2015)

1-(o-Tolyl)thiourea
por: Corrêa, Rodrigo S., et al.
Publicado: (2008)

1-Cyclopropyl-6-fluoro-7-(4-nitrosopiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
por: Li, Tao, et al.
Publicado: (2009)

(E)-3,5-Dimethyl-1-p-tolyl-4-(p-tolyldiazenyl)-1H-pyrazole
por: Bustos, Carlos, et al.
Publicado: (2012)

"Ejaculatory disorders and α(1)-adrenoceptor antagonists therapy: clinical and experimental researches"
por: Grasso, Marco, et al.
Publicado: (2006)

Novel selective β(1)-adrenoceptor antagonists for concomitant cardiovascular and respiratory disease
por: Baker, Jillian G., et al.
Publicado: (2017)

Use of α1‐adrenoceptor antagonists tamsulosin and alfuzosin and the risk of Alzheimer's disease
por: Latvala, Laura, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_60ts8e8p9vieo3gni6vjaeaqlj